Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1954 1
1958 3
1959 2
1960 4
1962 6
1963 3
1964 8
1965 7
1966 5
1967 19
1968 13
1969 12
1970 14
1971 10
1972 13
1973 12
1974 24
1975 14
1976 20
1977 23
1978 40
1979 36
1980 50
1981 38
1982 40
1983 50
1984 70
1985 56
1986 63
1987 52
1988 55
1989 57
1990 46
1991 57
1992 56
1993 66
1994 82
1995 83
1996 68
1997 102
1998 122
1999 101
2000 101
2001 90
2002 107
2003 108
2004 91
2005 121
2006 126
2007 129
2008 134
2009 153
2010 134
2011 159
2012 210
2013 203
2014 190
2015 167
2016 179
2017 174
2018 224
2019 274
2020 303
2021 309
2022 284
2023 276
2024 294
2025 284
2026 12

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

5,841 results

Results by year

Filters applied: . Clear all
Page 1
Human iPSC-liver organoid transplantation reduces fibrosis through immunomodulation.
Tadokoro T, Murata S, Kato M, Ueno Y, Tsuchida T, Okumura A, Kuse Y, Konno T, Uchida Y, Yamakawa Y, Zushi M, Yajima M, Kobayashi T, Hasegawa S, Kawakatsu-Hatada Y, Hayashi Y, Osakabe S, Maeda T, Kimura K, Mori A, Tanaka M, Kamishibahara Y, Matsuo M, Nie YZ, Okamoto S, Oba T, Tanimizu N, Taniguchi H. Tadokoro T, et al. Among authors: maeda t. Sci Transl Med. 2024 Jul 24;16(757):eadg0338. doi: 10.1126/scitranslmed.adg0338. Epub 2024 Jul 24. Sci Transl Med. 2024. PMID: 39047116
Cardiac Reprogramming and Gata4 Overexpression Reduce Fibrosis and Improve Diastolic Dysfunction in Heart Failure With Preserved Ejection Fraction.
Yamada Y, Sadahiro T, Nakano K, Honda S, Abe Y, Akiyama T, Fujita R, Nakamura M, Maeda T, Kuze Y, Onishi M, Seki M, Suzuki Y, Takeuchi C, Iwasaki YW, Murano K, Sakata-Yanagimoto M, Chiba S, Kato H, Sakamoto H, Hiramatsu Y, Ieda M. Yamada Y, et al. Among authors: maeda t. Circulation. 2025 Feb 11;151(6):379-395. doi: 10.1161/CIRCULATIONAHA.123.067504. Epub 2024 Dec 14. Circulation. 2025. PMID: 39673349
Preferential tumor targeting of HER2 by iPSC-derived CAR T cells engineered to overcome multiple barriers to solid tumor efficacy.
Hosking MP, Shirinbak S, Omilusik K, Chandra S, Kaneko MK, Gentile A, Yamamoto S, Shrestha B, Grant J, Boyett M, Cardenas D, Keegan H, Ibitokou S, Pavon C, Mizoguchi T, Ihara T, Nakayama D, Abujarour R, Lee TT, Clarke R, Goodridge J, Peralta E, Maeda T, Takagi J, Arimori T, Kato Y, Valamehr B. Hosking MP, et al. Among authors: maeda t. Cell Stem Cell. 2025 Jul 3;32(7):1087-1101.e4. doi: 10.1016/j.stem.2025.05.007. Epub 2025 Jun 4. Cell Stem Cell. 2025. PMID: 40472844
Melanoma skin cancer statistics derived from 7442 Japanese patients: Japanese melanoma study.
Fujisawa Y, Yoshikawa S, Takenouchi T, Mori S, Asai J, Uhara H, Ichigosaki Y, Fujimura T, Nakamura Y, Nakamura Y, Ohno F, Fukumoto T, Ozawa T, Namikawa K, Sugihara S, Hoashi T, Shimauchi T, Sawada Y, Iwata H, Maeda T, Miyagawa T, Shibayama Y, Hatta N, Kishi A, Ishikawa M, Kawahira H, Katoh N, Okuyama R. Fujisawa Y, et al. Among authors: maeda t. Int J Clin Oncol. 2025 May;30(5):844-855. doi: 10.1007/s10147-025-02747-9. Epub 2025 Apr 7. Int J Clin Oncol. 2025. PMID: 40192945 Free PMC article. Review.
Improved prognosis of advanced-stage extranodal NK/T-cell lymphoma: results of the NKEA-Next study.
Fujimoto A, Miyazaki K, Yakushijin K, Fujino T, Munakata W, Ejima Y, Maruyama D, Kubota N, Maeda T, Takizawa J, Hiramoto N, Takeuchi M, Sakai R, Fukuhara N, Taguchi S, Asano N, Yamaguchi M, Suzuki R. Fujimoto A, et al. Among authors: maeda t. Leukemia. 2025 Apr;39(4):909-916. doi: 10.1038/s41375-025-02527-4. Epub 2025 Feb 17. Leukemia. 2025. PMID: 39962328 Free PMC article.
Utility of allogeneic stem cell transplantation for adult Ph+ALL with complete molecular remission.
Nishiwaki S, Sugiura I, Fujisawa S, Hatta Y, Atsuta Y, Doki N, Kurahashi S, Ueda Y, Dobashi N, Maeda T, Matsumura I, Tanaka M, Kako S, Ichinohe T, Fukuda T, Ohtake S, Ishikawa Y, Miyazaki Y, Kiyoi H; Japan Adult Leukemia Study Group. Nishiwaki S, et al. Among authors: maeda t. Am J Hematol. 2024 May;99(5):806-815. doi: 10.1002/ajh.27237. Epub 2024 Feb 5. Am J Hematol. 2024. PMID: 38314662 Free article.
ctDNA improves prognostic prediction for patients with relapsed/refractory MM receiving ixazomib, lenalidomide, and dexamethasone.
Kogure Y, Handa H, Ito Y, Ri M, Horigome Y, Iino M, Harazaki Y, Kobayashi T, Abe M, Ishida T, Ito S, Iwasaki H, Kuroda J, Shibayama H, Sunami K, Takamatsu H, Tamura H, Hayashi T, Akagi K, Shinozaki T, Yoshida T, Mori I, Iida S, Maeda T, Kataoka K. Kogure Y, et al. Among authors: maeda t. Blood. 2024 Jun 6;143(23):2401-2413. doi: 10.1182/blood.2023022540. Blood. 2024. PMID: 38427753 Free article.
5,841 results